Laboratory Medicine ›› 2021, Vol. 36 ›› Issue (4): 357-361.DOI: 10.3969/j.issn.1673-8640.2021.04.001
Received:2020-03-07
Online:2021-04-30
Published:2021-04-28
Contact:
WANG Lei
CLC Number:
WANG Wei, WANG Lei. Influence of pre-analysis factors on clinical biochemical test results[J]. Laboratory Medicine, 2021, 36(4): 357-361.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2021.04.001
| [1] | 丛玉隆, 尹一兵, 陈瑜. 检验医学高级教程[M]. 2版. 北京: 人民军医出版社, 2010. |
| [2] | 李亚菊, 张晨, 陈锟. 分析前因素对血乳酸检测结果的影响[J]. 检验医学与临床, 2017,14(Z2):48-51. |
| [3] | 白巨明. 样本放置时间及温度对血氨检测结果的影响[J]. 检验医学与临床, 2015,12(19):2941-2942. |
| [4] | 全国卫生专业技术资格考试专家委员会. 临床医学检验技术(师)[M]. 北京: 人民卫生出版社, 2010. |
| [5] | 张寅珊. 血液样本放置时间对血糖检测结果的影响[J]. 健康之路, 2016,15(3):249-250. |
| [6] |
NARAYANAN S. The preanalytic phase an important component of laboratory medicine[J]. Am J Clin Pathol, 2000,113(3):429-452.
DOI URL PMID |
| [7] |
TURCHIANO M, NGUYEN C, FIERMAN A, et al. Impact of blood sample collection and processing methods on glucose levels in community outreach studies[J]. J Environ Public Health, 2013,2013:256151.
DOI URL PMID |
| [8] | 廖静, 丁霏, 罗薇, 等. 住院患者低血糖症的病因分析及鉴别方法初探[J]. 国际检验医学杂志, 2020,41(2):205-208. |
| [9] | 夏良裕, 徐二木, 曹新策, 等. 溶血对41个生化免疫项目的影响评估及溶血警告指数的确立[J]. 中华检验医学杂志, 2017,40(12):947-952. |
| [10] | 彭凤, 徐晓萍, 王琳, 等. 免疫透射比浊法和免疫散射比浊法检测特定蛋白的抗干扰能力比较[J]. 检验医学, 2013,28(2):142-145. |
| [11] |
JI J Z, MENG Q H. Evaluation of the interference of hemoglobin,bilirubin,and lipids on Roche Cobas 6000 assays[J]. Clin Chim Acta, 2011,412(17-18):1550-1553.
DOI URL PMID |
| [12] | 孙虹, 牛华, 赵崇吉, 等. 胆红素、血红蛋白和乳糜微粒对生化检测结果的干扰评价[J]. 国际检验医学杂志, 2011,32(21):2509-2512. |
| [13] | 陈池华. 溶血对临床尿酸检测的影响及评价[J]. 医学检验与临床, 2015,26(3):75-76. |
| [14] | 郭洪晨, 刘静. 胆红素对临床检验结果的干扰及消除[J]. 检验医学与临床, 2009,6(18):1573-1575. |
| [15] | 王缚鲲, 王宪灵, 安黎云, 等. 各种胆红素对氧化酶法测定血清尿酸浓度的影响[J]. 检验医学, 2005,20(1):4-6. |
| [16] |
AOKI Y, IHARA H, NAKAMURA H, et al. Effects of serum bilirubin on determination of uric acid by the uricase-peroxidase coupled reaction[J]. Clin Chem, 1992,38(7):1350-1352.
URL PMID |
| [17] | 刘蕊, 李刚, 崔小璠. 胆红素和血红蛋白对不同尿白蛋白检测方法结果干扰的研究[J]. 检验医学, 2012,27(7):564-567. |
| [18] |
SIMONSON P D, KIM K H, WINSTON-MCPHERSON G, et al. Characterization of bilirubin interference in three commonly used digoxin assays[J]. Clin Biochem, 2019,63:102-105.
DOI URL PMID |
| [19] | 孟凡超, 赵宗玲, 张梅, 等. 三酰甘油对临床生化检查的干扰剂量效应分析[J]. 检验医学与临床, 2014,11(18):2526-2528. |
| [20] | 宋霖, 戴雯, 张宁. 高浓度三酰甘油对免疫比浊法检测项目的影响[J]. 国际检验医学杂志, 2019,40(10):1236-1239. |
| [21] |
OHTAKE T, KANO S, WATANABE K. Interference in turbidimetric immunoassay for serum C-reactive protein due to serum protein abnormalities an immune complex and rheumatoid factor[J]. Rinsho Byori, 2000,48(8):752-759.
URL PMID |
| [22] |
KITAAKI S, HAYASHI N, SATO I, et al. Factors affecting non-specific reaction in latex agglutination turbidimetric immunoassay for detection of matrix metalloproteinase-3[J]. Rinsho Byori, 2015 , 63(4):427-434.
URL PMID |
| [23] | 黄佳芝, 徐萍, 刘宇嘉. 类风湿因子干扰免疫比浊法测定胱抑素 C 的原因(1例)[J]. 医疗装备, 2017,30(17):58-59. |
| [24] |
WU X Y, YIN Y F, TENG J L, et al. IgMκ paraprotein from gammopathy patient can bind to cardiolipin and interfere with coagulation assay:a case report[J]. BMC Immunol, 2017,18(1):32.
DOI URL PMID |
| [25] | HIRATA K, SARUWATARI J, ENOKI Y, et al. Possible false-negative results on therapeutic drug monitoring of phenytoin using a particle enhanced turbidimetric inhibition immunoassay in a patient with a high level of IgM[J]. Ther Drug Monit, 2014,36:553-555. |
| [26] | 韩建华, 程歆琦, 吴洁, 等. M蛋白对免疫透射比浊法和免疫散射比浊法检测免疫球蛋白的干扰[J]. 检验医学, 2019,34(3):197-201. |
| [27] | 杨杰, 李茂城, 尹小毛, 等. 27项特定蛋白项目检测结果分析及钩状效应的防范方法[J]. 检验医学与临床, 2019,16(1):8-12. |
| [28] | 张杰良, 黄雪珍, 莫和国, 等. 尿微量清蛋白抗原再添加检测技术与前带检查研究分析[J]. 重庆医学, 2017,46(28):3962-3964. |
| [29] |
SENA S F, SYED D, ROMEO R, et al. Lidocaine metabolite and creatinine measurements in the Ektachem 700:steps to minimize its impact on patient care[J]. Clin Chem, 1988,34(10):2144-2148.
URL PMID |
| [30] | GUO X, HOU L, CHENG X, et al. Strong negative interference by calcium dobesilate in sarcosine oxidase assays for serum creatinine involving the Trinder reaction[J]. Medicine(Baltimore), 2015,94(23):e905. |
| [31] | 余久如, 潘桂红, 鞠萍, 等. 羟苯磺酸钙对肌氨酸氧化酶法检测肌酐的干扰[J]. 中华检验医学杂志, 2013,36(2):161-164. |
| [32] |
PETRIDES A K, NESS M A, JUDGE D P, et al. Fluctuating creatinine in the cardiac unit[J]. Clin Chim Acta, 2015,447:52-54.
DOI URL PMID |
| [33] |
SAENGER A K, LOCKWOOD C, SNOZEK C L, et al. Catecholamine interference in enzymatic creatinine assays[J]. Clin Chem, 2009,55(9):1732-1736.
DOI URL PMID |
| [34] | 从玉隆, 杨建良. 大剂量青霉素对尿蛋白定性结果影响的探讨[J]. 中华检验医学杂志, 1994,17(3):167-168. |
| [35] | 张俊, 周芳芳, 徐玮, 等. 干化学法检测尿蛋白的影响因素分析[J]. 检验医学, 2018,33(10):916-919. |
| [36] | 李自越, 白重阳, 沈建军, 等. 注射用头孢替安对钒酸盐氧化法和干化学法测定的总胆红素浓度的影响[J]. 国际检验医学杂志, 2016,37(9):1197-1199. |
| [37] | 龙宪连, 刘晨, 于敏, 等. 头孢替安对总胆红素测定的干扰作用分析[J]. 中华检验医学杂志, 2010,33(8):761-763. |
| [1] | YANG Shu, YANG Lihua, SHENG Fengsong, JIANG Yonggen, QIAO Xuefei, ZHU Tianyue, YU Zifan, TANG Yiming. Drug resistance genes,virulence genes and molecular typing characteristics of 101 isolates of Campylobacter based on whole genome sequencing [J]. Laboratory Medicine, 2025, 40(7): 673-679. |
| [2] | BAO Rong, SHEN Jiajin, YAO Yumeng, MIAO Qing, WANG Beili, PAN Baishen, GUO Wei, HU Bijie. Distribution and drug resistance of clinical rapidly growing Mycobacterium in a Grade 3 Class A hospital [J]. Laboratory Medicine, 2025, 40(6): 540-544. |
| [3] | SUN Gang, SUN Hui, BAO Lina, LIU Xianwei, LU Mingyang, LIU Jing, TIAN Yuan. Drug resistance and molecular epidemiology of OS-MRSA in Hulunbuir,Inner Mongolia [J]. Laboratory Medicine, 2025, 40(6): 551-554. |
| [4] | YAO Ling, GAO Chunyan, LIU Minglei. Virulence characteristics of Streptococcus pneumoniae,PBP gene mutation and β-lactam resistance [J]. Laboratory Medicine, 2025, 40(5): 450-454. |
| [5] | CUI Lanying, GUO Dawen, YU Xiaochen, WANG Xi. Distribution characteristics and drug resistance analysis of fungi isolated from clinical samples from 2019 to 2023 in Heilongjiang [J]. Laboratory Medicine, 2025, 40(10): 1014-1018. |
| [6] | GUO Chaonan, WANG Yanyan, ZHANG Bei, PANG Jingying, CUI Feifei, ZHAO Yongxin, SU Bing. Analysis of drug resistance and virulence of Klebsiella pneumoniae from different clinical samples [J]. Laboratory Medicine, 2024, 39(9): 880-887. |
| [7] | WANG Yawen, ZHANG Yingying, NIU Wenyan. Influence of glycated hemoglobin A1c on pathogens of urinary tract infection in patients with type 2 diabetes mellitus [J]. Laboratory Medicine, 2024, 39(9): 895-899. |
| [8] | GONG Jingkai, OU Yuanzhu, YU Xiaoxuan, GE Danhong, LIN Feiran. Influence of hemoglobin,bilirubin,chylomicrons and calcium dobesilate on 3 determination systems [J]. Laboratory Medicine, 2024, 39(8): 749-758. |
| [9] | ZHANG Jialing, QI Jun. Interference and correction of chylemia on blood cell analysis parameters in tumor patients [J]. Laboratory Medicine, 2024, 39(8): 770-773. |
| [10] | WANG Xuqin, LIN Qianru, FENG Wanqing, DONG Yuan, YU Xiaolei, LIU Changhe, NING Zhen, SHEN Xin, PAN Qichao, LIN Yi. Validation of HIV-1 integrase genotyping sequence assay [J]. Laboratory Medicine, 2024, 39(4): 369-375. |
| [11] | ZHAO Yanan, XIAO Weili, CAO Qixin, YAN Yan, CUI Xiuge, ZHAO Jianping. Relation of drug resistance,serotypes and genotypes of Group B Streptococcus in perinatal pregnant females and pregnancy outcomes [J]. Laboratory Medicine, 2024, 39(4): 382-386. |
| [12] | DUAN Xuehan, WU Hua. Application of MALDI-TOF MS technology in clinical microbiological examination [J]. Laboratory Medicine, 2024, 39(4): 410-414. |
| [13] | CHEN Yu, ZHAO Ya, WANG Lin. Microbial distribution and drug resistance in chronic dacryocystitis [J]. Laboratory Medicine, 2024, 39(3): 256-259. |
| [14] | CHEN Huan, DONG Fang, LÜ Zhiyong, ZHEN Jinghui, CHEN Mei, SU Jianrong. Serotypes and drug resistance of invasive Streptococcus agalactiae in children [J]. Laboratory Medicine, 2024, 39(3): 260-264. |
| [15] | MA Chen, ZHANG Yi, LI Fang, WANG Jing, CHEN Wei. Clinical characteristics,drug resistance and poor prognosis factors in children with invasive pneumococcal disease with necrotizing pneumonia [J]. Laboratory Medicine, 2024, 39(3): 265-271. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
